Comparison of Anti-Acetylcholinesterase Activity of Bulb and Leaf Extracts of Sternbergia candida Mathew & T. Baytop
Studies on Alzheimer’s disease have been highlighted due to increasing prevalence of this disease. Oldest hypothesis about the pathophysiology strengthens the research of cholinesterase inhibitors for treatment. Amaryllidaceae plants are well known for alkaloids showing cholinesterase inhibiting activity. Among them, Sternbergia species gained attention as a source of metabolites of these alkaloid contents. Studies have focused mainly on the bulbs of these plants. In this study the potential acetylcholinesterase (AChE) inhibitory activity of endemic Sternbergia candida Mathew & T. Baytop (Sc) species was evaluated in both bulbs and leaves in comparison with lycorine. We report for the first time that methanol and chloroform leaf extracts of the plant show AChE inhibitory (AChEI) activity. Among the leaf extracts methanolic extract was much more potent than chloroform extract by means of AChE inhibition. Although IC50 values for methanolic extract was found to be lower than reference drug lycorine; this value of inhibition did not reach to a statistically significant level. Future studies aiming at investigation of the AChE inhibitory activity could be considered using leaves of the plant.
KeywordsSternbergia candida lycorine AchE inhibitory activity bulbs leaves
Unable to display preview. Download preview PDF.
The authors are thankful to Ernst Mach Grants and OEAD for the supports; Prof. Dr. Ulvi Zeybek and Prof. Dr. Levent Ustunes for facilities; Dr. Bio. Hasan Yildirim, Burak Isman and Ali Es for kind helps in collecting the plant.
- 1.Abdalla, S., Abu, M. Z., Sabri, S. (1993) Alkaloids of Sternbergia clusiani and effects of lycorine on guinea pig isolated pulmonary artery and heart. Fitoterapia 64, 518–523.Google Scholar
- 9.Davis, P. H. (1984) Flora of Turkey and the East Aegean Islands. University of Edinburgh Press, Edinburgh.Google Scholar
- 14.Hamulakova, S., Janovec, L., Hrabinova, M., Kristian, P., Kuca, K., Banasova, M., Imrich, J. (2012) Synthesis, design and biological evaluation of novel highly potent tacrine congeners for the treatment of Alzheimer’s disease. Eur. J. Med. Chem. 5, 523–531.Google Scholar
- 18.Mammadov, R., Kara, Y., Vaizogullar Ertem, H. (2011) Study on the phenolic content, antioxidant and antimicrobial effects of Sternbergia clusiana. Asian. J. Chem. 23, 5280–5284.Google Scholar
- 22.Orhan, I. E., Yilmaz, B. S., Altun, M. L., Saltan, G., Sener, B. (2011) Anti-acetylcholinesterase and antioxidant appraisal of the bulb extracts of five Sternbergia species. Rec. Nat. Prod. 5, 193–201.Google Scholar
- 25.Rodriguez-Franco, M. I., Fernandez-Bachiller, M. I., Perez, C., Hernandez-Ledesma, B., Bartolome, B. (2006) Novel tacrine-melatonin hybrids as dual-acting drugs for Alzheimer disease, with improved acetylcholinesterase inhibitory and antioxidant properties. J. Med. Chem. 49, 459–462.CrossRefGoogle Scholar
- 27.Stahl, S. M. (2008) Stahl’s essential psychopharmacology. Cambridge University Press, New York, 3: 899–943.Google Scholar
- 32.WHO (2002) WHO global strategy on traditional and alternative medicine. Public Health Rep., Geneva, pp. 1.Google Scholar
This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.